The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions
Open Access
- 17 April 2023
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 73, 24-35
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The use of stimulant medications for non-core aspects of ADHD and in other disordersNeuropharmacology, 2014
- ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong KongJournal of Attention Disorders, 2014
- Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide studyADHD Attention Deficit and Hyperactivity Disorders, 2014
- Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology, 2014
- ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysisInternational Journal of Epidemiology, 2014
- A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatmentBMC Medicine, 2012
- Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to AdulthoodPostgraduate Medicine, 2010
- Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysisThe British Journal of Psychiatry, 2009
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2007
- The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studiesPsychological Medicine, 2005